EASTERN COOPERATIVE ONCOLOGY GROUP

罗切斯特大学是一所健康和研究机构，非常适合帮助实现东部肿瘤协作组（ECOG）的目标。这些目标包括提高成人癌症患者的护理标准，通过转化研究促进对癌症生物学的理解，通过参与NCI支持的临床试验促进外展站点的治疗和支持性护理，探索创新的多模式治疗组合，并完善临床试验方法。 我们的30年ECOG计划投资于临床和基础实验室研究，患者护理和教育。 罗切斯特计划包括：* 罗切斯特大学癌症中心，多医院联盟（包括一个初级和三级保健中心和四个全面服务的社区医院）。 癌症中心为120万人口提供服务;* 8个外展设施位于美国东北部地区（相邻的纽约、马萨诸塞州和宾夕法尼亚州）。通过这项ECOG申请，我们的计划建议支持并实现其目标：1）参与多模式II/III期临床试验; 2）通过增加招募加速成人患者癌症治疗的进展; 3）加强基础科学临床互动; 4）支持癌症控制和预防计划; 5）通过高质量和及时的数据收集和出版物广泛传播信息; 6）继续为西非经共体的行政议程服务。

The University of Rochester is a health and research institute ideally suited to help achieve the goals of the Eastern Cooperative Oncology Group (ECOG). These goals include-improve standards of care to adult cancer patients, advance the understanding of cancer biology via translational research, promote treatment and supportive care to outreach sites through NCI-supported clinical trial participation, explore innovative multi-modality treatment combinations, and refine methodology of clinical trials. Our 30-year ECOG program is invested in clinical and basic laboratory research, patient care, and education. The Rochester program involves: * the University of Rochester Cancer Center, multi-hospital consortium (consisting of one primary tertiary care center and four full-service community hospitals). The Cancer Center serves a population of 1.2 million people; and * eight outreach facilities located in the regional Northeast section of the country (contiguous states of New York, Massachusetts and Pennsylvania). Through this ECOG application, our program proposes to support and attain its objectives to: 1) participate in multi-modal Phase II/III clinical trials; 2) accelerate the advances of cancer therapy in adult patients through increased recruitment; 3) enhance basic science clinical interactions; 4) support cancer control and prevention initiatives; 5) provide wide dissemination of information through quality and timely data collection and publications; 6) continue serve to the administrative agenda of ECOG.